Gefitinib vs Niraparib Tosylate Monohydrate
Gefitinib vs Niraparib Tosylate Monohydrate: Overview
This comparison examines the pharmacological differences between Gefitinib and Niraparib Tosylate Monohydrate.
Mechanism of Action
Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.
Pharmacokinetics
Half-life: Gefitinib β 48 hours.
Chemical Properties
Molecular Formula: Gefitinib β C22H24ClFN4O3.
Molecular Weight: Gefitinib β 446.9000 g/mol.
Type: Gefitinib β Small molecule; Niraparib Tosylate Monohydrate β Small molecule.